Boston, MA -- (SBWIRE) -- 07/16/2014 -- In 2013, sales of analgesics increased by 12% in current value terms, reaching R$4 billion. Following the same trend perceived in 2012 of double-digit growth, sales were mainly stimulated by the growing number of Brazilians leaving the low-income segment, and joining the middle-classes. These emerging middle class consumers have many duties every day, from going to work, taking care of the family, cleaning the house, and buying groceries, to name a few. As a result, they cannot let a health condition stop them from performing those activities. Due to this fact, every time these consumers feel any indication of muscular pain, headache or back pain, they purchase analgesics in order to obtain fast relief, so they can continue on with their activities.
Sanofi-Aventis Farmaceutica remained as the leader of analgesics in 2013, with 19% current value share. Dorflex, one important brand from Sanofi-Aventis retained its leading position in combination products - analgesics with 28% value share in 2013.
View Full Report Details and Table of Contents
Analgesics is predicted to post a value CAGR of 5% in constant 2013 prices during the forecast period. This growth is expected to be driven by the emerging middle-classes, who are increasingly concerned about wellbeing and how to treat minor conditions in an effective way. Robust marketing campaigns are expected in the next years in order to draw consumers, especially the emerging middle-classes, mostly driven by television and radio advertising and social media.
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Brazil with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Brazil market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
- What is the market size of Analgesics in Brazil?
- What are the major brands in Brazil?
- Are combination products with acetaminophen still popular?
Reasons to Get this Report
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Healthcare research reports at Fast Market Research
You may also be interested in these related reports:
- Analgesics in Portugal
- Analgesics in the Czech Republic
- Analgesics in New Zealand
- Analgesics in Israel
- Analgesics in Indonesia
- Analgesics in the United Kingdom
- Analgesics in Venezuela
- Analgesics in South Korea
- Analgesics in India
- Analgesics in Ireland